DK0626961T3 - Fremgangsmåde til nitrosering - Google Patents
Fremgangsmåde til nitroseringInfo
- Publication number
- DK0626961T3 DK0626961T3 DK93903271T DK93903271T DK0626961T3 DK 0626961 T3 DK0626961 T3 DK 0626961T3 DK 93903271 T DK93903271 T DK 93903271T DK 93903271 T DK93903271 T DK 93903271T DK 0626961 T3 DK0626961 T3 DK 0626961T3
- Authority
- DK
- Denmark
- Prior art keywords
- formula
- compounds
- nitrosation
- chem
- nitrosating
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 230000009935 nitrosation Effects 0.000 title 1
- 238000007034 nitrosation reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929203688A GB9203688D0 (en) | 1992-02-20 | 1992-02-20 | Novel process |
| PCT/GB1993/000291 WO1993017018A1 (en) | 1992-02-20 | 1993-02-11 | Nitrosation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0626961T3 true DK0626961T3 (da) | 2000-11-06 |
Family
ID=10710781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93903271T DK0626961T3 (da) | 1992-02-20 | 1993-02-11 | Fremgangsmåde til nitrosering |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US5545740A (enExample) |
| EP (2) | EP0984008A3 (enExample) |
| JP (1) | JP3288704B2 (enExample) |
| KR (1) | KR100261530B1 (enExample) |
| AT (1) | ATE194341T1 (enExample) |
| AU (1) | AU669355B2 (enExample) |
| CA (1) | CA2131019C (enExample) |
| DE (1) | DE69328962T2 (enExample) |
| DK (1) | DK0626961T3 (enExample) |
| ES (1) | ES2147749T3 (enExample) |
| GB (1) | GB9203688D0 (enExample) |
| GR (1) | GR3034295T3 (enExample) |
| MX (1) | MX9300875A (enExample) |
| NZ (1) | NZ246940A (enExample) |
| PT (1) | PT626961E (enExample) |
| TW (1) | TW224466B (enExample) |
| WO (1) | WO1993017018A1 (enExample) |
| ZA (1) | ZA931132B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9300875A (es) | 1992-02-20 | 1993-08-31 | Smithkline Beecham Plc | Procedimiento para la preparacion de compuestos azabiciclicos. |
| GB9409705D0 (en) * | 1994-05-14 | 1994-07-06 | Smithkline Beecham Plc | Novel compounds |
| GB9421472D0 (en) * | 1994-10-25 | 1994-12-07 | Smithkline Beecham Plc | Novel methods |
| GB9615628D0 (en) * | 1996-07-25 | 1996-09-04 | Smithkline Beecham Plc | Formulation |
| AU6966998A (en) * | 1997-04-11 | 1998-11-11 | Eli Lilly And Company | Composition for treating pain |
| AU7107998A (en) * | 1997-04-11 | 1998-11-11 | Eli Lilly And Company | Method for treating schizophrenia |
| US7678363B2 (en) * | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| CA2651813A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| CA2662491A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1600969A (en) | 1977-01-07 | 1981-10-21 | Acf Chemiefarma Nv | Heterocyclic compounds |
| US4937239A (en) * | 1989-02-13 | 1990-06-26 | Warner-Lambert Company | Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents |
| DE69034146T2 (de) * | 1989-04-13 | 2005-07-14 | Beecham Group P.L.C., Brentford | Chemische Verbindungen |
| US5418240A (en) | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
| DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| MX9300875A (es) | 1992-02-20 | 1993-08-31 | Smithkline Beecham Plc | Procedimiento para la preparacion de compuestos azabiciclicos. |
-
1992
- 1992-02-18 MX MX9300875A patent/MX9300875A/es unknown
- 1992-02-20 GB GB929203688A patent/GB9203688D0/en active Pending
-
1993
- 1993-02-11 PT PT93903271T patent/PT626961E/pt unknown
- 1993-02-11 AT AT93903271T patent/ATE194341T1/de not_active IP Right Cessation
- 1993-02-11 EP EP99203614A patent/EP0984008A3/en not_active Withdrawn
- 1993-02-11 WO PCT/GB1993/000291 patent/WO1993017018A1/en not_active Ceased
- 1993-02-11 EP EP93903271A patent/EP0626961B1/en not_active Expired - Lifetime
- 1993-02-11 AU AU34607/93A patent/AU669355B2/en not_active Ceased
- 1993-02-11 CA CA002131019A patent/CA2131019C/en not_active Expired - Fee Related
- 1993-02-11 JP JP51461493A patent/JP3288704B2/ja not_active Expired - Fee Related
- 1993-02-11 DK DK93903271T patent/DK0626961T3/da active
- 1993-02-11 KR KR1019940702881A patent/KR100261530B1/ko not_active Expired - Fee Related
- 1993-02-11 ES ES93903271T patent/ES2147749T3/es not_active Expired - Lifetime
- 1993-02-11 NZ NZ246940A patent/NZ246940A/en unknown
- 1993-02-11 DE DE69328962T patent/DE69328962T2/de not_active Expired - Fee Related
- 1993-02-18 ZA ZA931132A patent/ZA931132B/xx unknown
- 1993-02-22 TW TW082101219A patent/TW224466B/zh active
-
1994
- 1994-08-11 US US08/284,617 patent/US5545740A/en not_active Expired - Lifetime
-
2000
- 2000-08-31 GR GR20000401982T patent/GR3034295T3/el not_active IP Right Cessation
-
2002
- 2002-05-30 US US10/158,502 patent/US6596869B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| MX9300875A (es) | 1993-08-31 |
| ZA931132B (en) | 1993-10-14 |
| ES2147749T3 (es) | 2000-10-01 |
| JPH07504180A (ja) | 1995-05-11 |
| TW224466B (enExample) | 1994-06-01 |
| AU669355B2 (en) | 1996-06-06 |
| EP0984008A2 (en) | 2000-03-08 |
| EP0626961B1 (en) | 2000-07-05 |
| CA2131019C (en) | 2002-12-24 |
| CA2131019A1 (en) | 1993-08-21 |
| KR100261530B1 (ko) | 2000-08-01 |
| EP0984008A3 (en) | 2000-05-03 |
| GR3034295T3 (en) | 2000-12-29 |
| PT626961E (pt) | 2000-10-31 |
| HK1012366A1 (en) | 1999-07-30 |
| DE69328962D1 (de) | 2000-08-10 |
| WO1993017018A1 (en) | 1993-09-02 |
| GB9203688D0 (en) | 1992-04-08 |
| US20020143185A1 (en) | 2002-10-03 |
| KR950700292A (ko) | 1995-01-16 |
| US6596869B2 (en) | 2003-07-22 |
| ATE194341T1 (de) | 2000-07-15 |
| AU3460793A (en) | 1993-09-13 |
| NZ246940A (en) | 1996-06-25 |
| DE69328962T2 (de) | 2000-12-28 |
| US5545740A (en) | 1996-08-13 |
| EP0626961A1 (en) | 1994-12-07 |
| JP3288704B2 (ja) | 2002-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0626961T3 (da) | Fremgangsmåde til nitrosering | |
| FI931888A0 (fi) | Kramploesande cykliska fruktopyranossulfiter -och sulfater | |
| ES2054826T3 (es) | Peptidos con actividad inhibidora de colagenasa. | |
| HUT57043A (en) | Process for producing pharmaceutical solutions comprising macrolide | |
| DE3775882D1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
| ATE122042T1 (de) | Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| MX21088A (es) | N-heteroanil-purin-6-aminas, y un proceso para su preparacion y su uso como medicamentos. | |
| NO894349D0 (no) | Tienopyridin-type mevalonolaktoner. | |
| NO932232D0 (no) | Organiske cerium (iv)-forbindelser, deres fremstilling oganvendelse | |
| ES8304971A1 (es) | Un procedimiento para la preparacion de derivados de tiocarbapenem 3-sustituidos. | |
| DK154837C (da) | Oxadiazolylimidazobenzodiazepinforbindelse og farmaceutisk praeparat indeholdende samme | |
| DE69401163D1 (de) | Umwandlungsverfahren von Lorabef Dihydrate in Loracarbef Monohydrate | |
| FI933928A0 (fi) | Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel | |
| CA2193310A1 (fr) | Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| DK162188D0 (da) | Fremgangsmaade til fremstilling af pentandionderivater | |
| DK579489D0 (da) | Heterocykliske forbindelser | |
| TH13944A (th) | สารประกอบเฮเทโรไซคลิค |